Search - tctmd.com

Displaying 201 - 212 of 212

Sort: Relevancy | Date

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Duplication of Invasive Services Still Leaves Many Patients Without Timely Access

July 25, 2013

News Daily News

Study Looks at AMI Care in French Universal Coverage System

Jason Kahn

October 10, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

CME

Advertisement

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

‘Value’ of PCI Varies Widely Across VA Hospitals

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Duplication of Invasive Services Still Leaves Many Patients Without Timely Access

Study Looks at AMI Care in French Universal Coverage System

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content